Exp Mol Med.  2005 Aug;37(4):297-310.

Iron chelator inducesMIP-3alpha/CCL20 in human intestinal epithelial cells: implication for triggeringmucosal adaptive immunity

Affiliations
  • 1Department of Physiology, Kyungpook National University School of Medicine, Daegu 700-422, Korea. cdjun@mail.knu.ac.kr
  • 2Digestive Disease Research Institute, Wonkwang University School of Medicine, Iksan, Jeonbuk 570-749, Korea.
  • 3Department of Pathology, Wonkwang University School of Dentistry, Iksan, Jeonbuk 570-749, Korea.
  • 4Department of Biology, Chonbuk National University, Jeonju, Jeonbuk 561-756, Korea.

Abstract

A previous report by this laboratory demonstrated that bacterial iron chelator (siderophore) triggers inflammatory signals, including the production of CXC chemokine IL-8, in human intestinal epithelial cells (IECs). Microarray-based gene expression profiling revealed that iron chelator also induces macrophage inflammatory protein 3 alpha (MIP-3alpha)/ CC chemokine-ligand 20 (CCL20). As CCL20 is chemotactic for the cells involved in host adaptive immunity, this suggests that iron chelator may stimulate IECs to have the capacity to link mucosal innate and adaptive immunity. The basal medium from iron chelator deferoxamine (DFO)-treated HT-29 monolayers was as chemotactic as recombinant human CCL20 at equivalent concentrations to attract CCR6+ cells. The increase of CCL20 protein secretion appeared to correspond to that of CCL20 mRNA levels, as determined by real-time quantitative RT-PCR. The efficacy of DFO at inducing CCL20 mRNA was also observed in human PBMCs and in THP-1 cells, but not in human umbilical vein endothelial cells. Interestingly, unlike other proinflammatory cytokines, such as TNF-alpha and IL-1beta, a time-dependent experiment revealed that DFO slowly induces CCL20, suggesting a novel mechanism of action. A pharmacologic study also revealed that multiple signaling pathways are differentially involved in CCL20 production by DFO, while some of those pathways are not involved in TNF-alpha-induced CCL20 production. Collectively, these results demonstrate that, in addition to some bacterial products known to induce host adaptive immune responses, direct chelation of host iron by infected bacteria may also contribute to the initiation of host adaptive immunity in the intestinal mucosa.

Keyword

CCL20 protein, human; deferoxamine; immunity, active; iron; iron chelator; tumor necrosis factor-alpha

MeSH Terms

Calcium/metabolism
Cell Movement/drug effects
Chemokines, CC/genetics/*metabolism
Deferoxamine/*pharmacology
Egtazic Acid/analogs & derivatives/pharmacology
HT29 Cells
Humans
Immunity, Mucosal/*drug effects
Intestinal Mucosa/*drug effects/immunology/metabolism
Iron Chelating Agents/*pharmacology
Macrophage Inflammatory Proteins/genetics/*metabolism
NF-kappa B/metabolism
Phosphoprotein Phosphatase/physiology
Protein Transport/drug effects
Protein-Serine-Threonine Kinases/physiology
RNA, Messenger/genetics/metabolism
Receptors, Chemokine/metabolism
Research Support, Non-U.S. Gov't
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr